Frias, MarioRivero-Juarez, AntonioRodriguez-Cano, DiegoCamacho, AngelaLopez-Lopez, PedroRisalde, Maria AngelesManzanares-Martin, BarbaraBrieva, TeresaMachuca, IsabelRivero, Antonio2023-01-252023-01-252017-11-27Frias M, Rivero-Juárez A, Rodriguez-Cano D, Camacho Á, López-López P, Risalde MÁ, et al. HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance. Sci Rep. 2018 Jan 12;8(1):659http://hdl.handle.net/10668/12007IFNL3 is the strongest predictor of spontaneous resolution (SR) of hepatitis C virus (HCV), however, consideration of IFNL3 genotype alone is of limited clinical value for the prediction of SR or chronic HCV infection. The objective of this study was to analyze the impact of HLA-B, HLA-C and KIRs on SR, as well as their additive effects on the predictive value of the IFNL3 genotype. We conducted a retrospective study of HIV patients that included both SR and chronic HCV patients. In our study, 61.6% of patients with IFNL3 CC achieved SR, and 81.5% with non-CC genotypes did not achieve SR. HLA-B*44, HLA-C*12, and KIR3DS1 were identified as predictive factors for SR, with percentages of 77.4%, 85.7% and 86.2%, respectively, for patients who did not experience SR. The presence of at least one of these three markers, defined as a genetically unfavorable profile (GUP), combined with the IFNL3 non-CC genotype showed a value of 100% for non-SR. The absence of the three markers, defined as a genetically favorable profile (GFP), in addition to the IFNL3 CC genotype showed a percentage of 74.1% for SR. The combination of these markers in addition to the IFNL3 genotype improves the predictive value of IFNL3 for SR of acute HCV infection in HIV patients, which would be clinically valuable.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Genetic markersHIV infectionsHLA-B44 antigenHLA-C antigensHepacivirusFemaleHepatitis C, chronicHumansInterferonsInterleukinsMaleMiddle agedPredictive value of testsReceptors, KIR3DS1Retrospective studiesViral loadresearch article29330418open accessCarga viralEstudios retrospectivosHepatitis C crónicaInterferonesInterleucinasReceptores KIR3DS1Valor predictivo de las pruebas10.1038/s41598-017-17531-72045-2322PMC5766528https://www.nature.com/articles/s41598-017-17531-7.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766528/pdf